Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.

In a heated live stream watched by millions, Alex Jones and Nick Fuentes teamed up to talk through the newest release of ...

Hosting Kwanzaa celebrations for more than 20 years, Malcolm X College continues to honor African heritage and culture during ...

What is the current share price of Vor Biopharma Inc (VOR)? Vor Biopharma Inc's (VOR) current share price is $12.81. This constitutes a price movement of 24.37% when compared to the share price 7 days ...

In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...

Vor Biopharma (VOR) has jumped onto investors’ radar after strong Phase 3 data for telitacicept in IgA nephropathy, paired with upbeat new Wall Street coverage that frames the drug’s long term ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Vor Biopharma strengthens presence in engineered cell therapy Precision platforms support expanding hematologic treatment design Clinical development enhances visibility across oncology research Vor ...

Investing.com - JPMorgan has initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a price target of $43.00, highlighting the potential of the company’s telitacicept ...

Investing.com - JPMorgan initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a $43.00 price target, citing the potential of its telitacicept drug. The target ...

Vor Biopharma shares fell sharply Tuesday in premarket trading after the company priced its $100 million offering below recent trading prices. Shares traded 31% lower ahead of the morning bell at ...

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...